There are 2,125 results relating to "Comprar L"
|
Questions and Answers
Date answered:
26 June 2000
S1W-06338
Colin BellMemberScottish Higher Education Funding Council 4Ms Christine MayMemberScottish Homes44Canon L S SmithMemberScottish Homes4 Mr Ian BorthwickTayside Primary Care NHS Trust4 Mr David HamiltonMemberEast of Scotland Water Authority44Mr Donald CampbellMemberWest of Scotland Water Authority4 Ms Rita Miller Member (subsequ...
Date published:
21 November 2019
The Children (Scotland) Bill
Retrieved from <a href="http://external.parliament.scot/GettingInvolved/Petitions/PE01635" target="_blank">http://external.parliament.scot/GettingInvolved/Petitions/PE01635</a>3Trinder, L., Hunt, J., Macleod, A., Pearce, J., & Woodward, H. (2013).
Date published:
26 June 2019
Health and social care integration: spending and performance update
Retrieved from <a href="http://www.scottish.parliament.uk/ResearchBriefingsAndFactsheets/S4/SB_13-50.pdf" target="_blank">http://www.scottish.parliament.uk/ResearchBriefingsAndFactsheets/S4/SB_13-50.pdf</a> [accessed 19 June 2019], and 16/70 Integration of Health and Social Care4Burgess, L. (2016, August 24). Integration of Health and Social Car...
Date published:
6 December 2017
Income Tax in Scotland: 2017 update
Cambridge Journal of Economics, 30(2), 235-252. doi: https://doi.org/10.1093/cje/bei057There is some evidence that those with high incomes choose their place of residence depending on their income tax liability.2Feld, L., & Kirchgässner, G. (2000).
Official Report
Meeting date:
28 June 2000
Enterprise and Lifelong Learning Committee, 28 Jun 2000
It states that students must"Be attending a part-time course consisting of at leased 50% of a full-time course"—spelt L-E-A-S-E-D. Really? That is a spelling mistake.
Questions and Answers
Date answered:
22 October 2003
S2W-03061
The figures relateto the period 1993-97, the latest period for which internationally comparableinformation is available.Table 1 - Malignant Melanomaof the Skin (C43): International Comparisons of Incidence RatesAge-standardised Incidence Ratesper 100,000 Person-years at Risk (World Standard Population) for Selected Countriesor Registries; Ranked; by Sex: Period 1993-97 Males Females Australia, New South Wales 36.9 New Zealand 30.6 New Zealand 32.8 Australia, New South Wales 25.9 USA, California, San Francisco: Non-Hispanic White 18.2 Denmark 13.4 USA, Connecticut: White 16.7 Switzerland, Vaud 13.4 Switzerland, Vaud 14.0 USA, California, San Francisco: Non-Hispanic White 12.6 Austria, Tyrol 11.2 USA, Connecticut: White 12.3 Canada, Nova Scotia 11.1 Austria, Tyrol 10.9 Denmark 10.5 Scotland 9.9 Scotland 7.1 Canada, Nova Scotia 9.0 Slovenia 6.8 England, Yorkshire 6.9 Italy, Varese Province 5.5 Slovenia 6.8 England, Yorkshire 4.8 Italy, Varese Province 5.9 Slovakia 4.8 Poland, Cracow 5.8 Poland, Cracow 4.7 Estonia 5.4 Estonia 3.7 Slovakia 5.3 Spain, Zaragoza (1991-1995) 2.7 Spain, Zaragoza (1991-1995) 3.3 Thailand, Khon Kaen 0.5 Thailand, Khon Kaen 0.4 China, Shanghai 0.3 China, Shanghai 0.3 India, Bangalore 0.3 India, Bangalore 0.3 Japan, Miyagi Prefecture 0.3 Japan, Miyagi Prefecture 0.3 Table 2 - Non-melanoma SkinCancer (C44): International Comparisons of Incidence RatesAge-standardised Incidence Ratesper 100,000 Person-years at Risk (World Standard Population) for Selected Countriesor Registries; Ranked; by Sex: Period 1993-97 Males Females Switzerland, Vaud 99.4 Switzerland, Vaud 81.6 Scotland 68.3 Denmark 51.5 Denmark 58.9 Scotland 47.3 England, Yorkshire 54.4 England, Yorkshire 40.3 Slovakia 43.1 Slovakia 33.6 Spain, Zaragoza (1991-1995) 39.8 Estonia 22.5 Italy, Varese Province 34.4 Spain, Zaragoza (1991-1995) 22.5 Slovenia 30.0 Slovenia 22.3 Estonia 22.9 Italy, Varese Province 18.3 Austria, Tyrol 22.1 Austria, Tyrol 17.1 Poland, Cracow 14.9 Poland, Cracow 11.6 Thailand, Khon Kaen 4.0 Thailand, Khon Kaen 3.1 Japan, Miyagi Prefecture 2.7 Japan, Miyagi Prefecture 1.6 India, Bangalore 1.3 India, Bangalore 1.2 China, Shanghai 1.1 China, Shanghai 1.0 Australia, New South Wales*** - Australia, New South Wales*** - Canada, Nova Scotia* - Canada, Nova Scotia* - New Zealand* - New Zealand* - USA, California, San Francisco: Non-Hispanic White* - USA, California, San Francisco: Non-Hispanic White* - USA, Connecticut: White** - USA, Connecticut: White** - Source:Parkin DM, Whelan SL, Ferlay J, Teppo L...
Questions and Answers
Date answered:
19 January 2005
S2W-13117
To ask the Scottish Executive, further to the answer to question S2W-12713 by Cathy Jamieson on 14 December 2004, what the average fine has been, where a monetary penalty was awarded, for a first offender convicted of (a) non-sexual crimes of violence, (b) serious assault, (c) robbery, (d) crimes of indecency, (e) rape, (f) attempted rape, (g) indecent assault, (h) crimes of dishonesty, (i) housebreaking, (j) shoplifting, (k) fraud, (l...
Questions and Answers
Date answered:
14 April 2000
S1W-04698
To ask the Scottish Executive whether a comprehensive policy and financial management review has been carried out on (a) Scottish National Heritage, (b) Scottish Environment Protection Agency, (c) Historic Scotland, (d) West of Scotland Water Authority, (e) North of Scotland Water Authority, (f) East of Scotland Water Authority, (g) Crofters Commission, (h) Highlands and Islands Airports Ltd, (i) Caledonian MacBrayne Ltd, (j) Scottish Fisheries Protection Agency, (k) Advisory Committee on Sites of Special Scientific Interest, (l...
Official Report
Meeting date:
5 December 2006
Subordinate Legislation Committee, 05 Dec 2006
Are members happy with paragraph 2(1C)(l) of schedule 4?Members indicated agreement.
Questions and Answers
Date answered:
3 March 2006
S2W-23436
Laboratory 2002-03 No. of Tests 2003-04 No. of Tests 2004-05 No. of Tests Food safety Microbiology laboratory Bacillus sp 11 4 41 C Botulinum toxin 7 12 6 C Botulinum culture 0 0 4 Clostridium sp 16 7 28 Listeria species 0 0 2 L monocytogenes 17 8 63 Staph aureus 62 0 0 Sub total cost £5,096 £5,783 £ 9,366 Respiratory and Systemic Infection Laboratory Diphtheria antitoxin 5 7 4 Bartonella serology 130 59 126 Tetanus serology 7 12 28 Legionella pneumophila serology 1 0 0 Mycoplasma serology/culture 2 0 1 Haemophilus influenzae typing 46 50 21 Streptococcal typing / speciation 0 3 50 Sub total cost £7,937.75 £6,961 £9,937.74 Enteric, Respiratory and Neurological Virus laboratory Influenza strain typing 45 46 3 Poliovirus serology 4 7 6 SRSV PCR/NLV PCR 168 2 0 Parvovirus B19 55 70 43 Polyoma virus 42 125 124 Measles mumps rubella serology/PCR 18 154 189 Herpes B virus 94 5 0 Other virus PCR 0 0 19 Sub total cost £13,772 £11,964 £12,348 Laboratory of healthcare associated infection Species identification 77 65 53 Coagulase negative identification 9 0 3 Enterococcal identification 117 104 30 Staphylococcus phage type 90 119 2 Group A serodiagnosis 280 395 466 S aureus serodiagnosis 42 37 36 Gram negative typing 49 47 0 Exfoliative toxin testing 2 14 Molecular typing 11 31 141 Sub total cost £20,071 £21,997 £19,747 Antibiotic and resistance Monitoring Reference Laboratory Antibiotic resistance tests 217 242 143 Sub total cost £7,595 £8,470 £5,005 Laboratory of enteric pathogens E Coli serotyping 14 0 0 Yersinia serodiagnosis 157 99 71 Sub total cost £3,420 £2,018 £1,562 Sexually transmitted and Blood Borne Virus Laboratory Hepatitis 0 0 0 HSV serology 5 0 5 Anti HIV testing 0 0 33 HIV proviral DNA 0 0 1 HPV DNA/Typing 0 0 4 Sub total cost £75 0 £732 Leptospira reference Unit (Hereford PHL) Leptospira serology 117 76 104 Sub total cost £1,249 £743 £1,297 Total cost per annum £59,215 £57,936 £59,996 Annual payment from NSD £41,200 £57,042 £55,001 S2W-23436
